Covered recipient · General Payments record
NANCY I DAY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$1,874.72
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $541.49 | 25 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $249.24 | 14 |
| BOSTON SCIENTIFIC CORPORATION | $67.56 | 1 |
| Janssen Pharmaceuticals, Inc | $56.38 | 2 |
| Acerta Pharma LLC | $45.97 | 1 |
| Gilead Sciences, Inc. | $23.78 | 1 |
| Astellas Pharma US Inc | $20.39 | 1 |
| PFIZER INC. | $18.93 | 1 |
| CeQur Corporation | $16.25 | 1 |
| Vanda Pharmaceuticals Inc. | $14.89 | 1 |
| GlaxoSmithKline, LLC. | $14.52 | 1 |
| Lilly USA, LLC | $13.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.60 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636947 | CMS |
| ABBVIE INC. | $8.03 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636953 | CMS |
| ABBVIE INC. | $11.27 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636961 | CMS |
| ABBVIE INC. | $20.53 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636969 | CMS |
| ABBVIE INC. | $16.30 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636975 | CMS |
| ABBVIE INC. | $14.21 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636981 | CMS |
| ABBVIE INC. | $20.61 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636989 | CMS |
| ABBVIE INC. | $26.73 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003636995 | CMS |
| ABBVIE INC. | $12.28 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003637003 | CMS |
| ABBVIE INC. | $16.74 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003637009 | CMS |
| ABBVIE INC. | $22.30 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003637019 | CMS |
| ABBVIE INC. | $30.70 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003637025 | CMS |
| ABBVIE INC. | $12.37 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003637033 | CMS |
| ABBVIE INC. | $20.57 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003637039 | CMS |
| Astellas Pharma US Inc | $20.39 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034065543 | CMS |
| AstraZeneca Pharmaceuticals LP | $45.97 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015892249 | CMS |
| Boston Scientific Corporation | $67.56 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022146841 | CMS |
| CeQur Corporation | $16.25 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1028682129 | CMS |
| Gilead Sciences, Inc. | $23.78 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025680981 | CMS |
| GlaxoSmithKline, LLC. | $14.52 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004350047 | CMS |
| Janssen Pharmaceuticals, Inc | $30.06 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987760491 | CMS |
| Janssen Pharmaceuticals, Inc | $26.32 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987760495 | CMS |
| Lilly USA, LLC | $13.58 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033463657 | CMS |
| PFIZER INC. | $18.93 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049647397 | CMS |
| Vanda Pharmaceuticals Inc. | $14.89 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051554923 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.